The notices it replaced
- Reissues: PAR-13-036 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)
Replaced by PAR-18-913.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,288,701 in first-year total cost, median $561,786.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRLB-5 (O1)]4
- Special Emphasis Panel[ZCA1 TCRB-Y (O1)]3
- Special Emphasis Panel[ZCA1 RPRB-6 (O2)]1
- Special Emphasis Panel[ZCA1 SRLB-Y (J1)]1
- Special Emphasis Panel[ZCA1 TCRB-T (M1)]1
Most frequent institutions
- FRED HUTCHINSON CANCER RESEARCH CENTER2
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- CASE WESTERN RESERVE UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype1U01CA222163-01A1 | BRESALIER, ROBERT SDAVIS, JENNIFER SARAH | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $448,631 | ZCA1 |
| 2017 | Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis1U01CA217078-01 | BISSONNETTE, BRUCE MARCZHANG, WEI | UNIVERSITY OF CHICAGO, IL | $613,236 | ZCA1 |
| 2016 | Incorporating Biomarkers to Improve Lung Cancer Risk Prediction1U01CA194733-01A1 · under PAR-13-036 | FENG, ZIDINGHANASH, SAMIR MTAMMEMAGI, MARTIN C | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $692,318 | ZCA1 |
| 2015 | Molecular Risk Stratification for Colonoscopic Surveillance1U01CA182367-01A1 · under PAR-13-036 | CHAN, ANDREW T | MASSACHUSETTS GENERAL HOSPITAL, MA | $656,638 | ZCA1 |
| 2014 | Colorectal Tumor Risk Prediction in the PLCO Trial1U01CA185094-01A1 · under PAR-13-036 | PETERS, ULRIKE | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $736,996 | ZCA1 |
| 2014 | Translating gene-calcium interactions to precision medicine for colorectal cancer1U01CA182364-01 · under PAR-13-036 | DAI, QIEDWARDS, TODD L | VANDERBILT UNIVERSITY, TN | $635,725 | ZCA1 |
| 2014 | 15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi1U01CA181770-01 · under PAR-13-036 | LI, LI | CASE WESTERN RESERVE UNIVERSITY, OH | $561,786 | ZCA1 |
| 2014 | Oral microbiome in esophageal adenocarcinoma1U01CA182370-01 · under PAR-13-036 | AHN, JIYOUNGPEI, ZHIHENG | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $539,256 | ZCA1 |
| 2014 | Varicella virus antigens in glioma etiology and survival1U01CA182371-01 · under PAR-13-036 | WIEMELS, JOSEPH LEO | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $535,578 | ZCA1 |
| 2014 | Validation of findings from the Epigenome-Wide Association Study of Breast Cancer1U01CA184910-01A1 · under PAR-13-036 | STURGEON, SUSAN R | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $518,726 | ZCA1 |
| 2014 | Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation1U01CA185097-01 · under PAR-13-036 | HOUGHTON, A MCGARRYLAMPE, PAUL D. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $349,811 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.